- Bevorzugter Name
- Escholerin
- IUPAC
- [(1S,2S,6S,9S,10S,11R,12R,13S,14S,15S,16S,17R,18R,19S,22S,23R,25R)-16,17-diacetyloxy-10,12,14,23-tetrahydroxy-6,10,19-trimethyl-22-[(Z)-2-methylbut-2-enoyl]oxy-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-13-yl] (2R)-2-methylbutanoate
- Englischer Name
- 6α,7α-Diacetoxy-4α,9-epoxy-15α-[(R)-2-methyl-1-oxobutoxy]-3β-[[(Z)-2-methyl-1-oxo-2-butenyl]oxy]cevane-4,14,16β,20-tetrol
- Summenformel
- C41H61NO13
- Molmasse
- 775.93
Namen und Synonyme
EscholerinC3AAP9GKQN663-93-4UNII-C3AAP9GKQNCevane-3,4,6,7,14,15,16,20-octol, 4,9-epoxy-, 6,7-diacetate 15-((2R)-2-methylbutanoate) 3-((2Z)-2-methyl-2-butenoate), (3beta,4alpha,6alpha,7alpha,15alpha,16beta)-Cevane-3,4,6,7,14,15,16,20-octol, 4,9-epoxy-, 6,7-diacetate 15-(2-methylbutanoate) 3-(2-methyl-2-butenoate), (3beta(Z),4alpha,6alpha,7alpha,15alpha(R),16beta)-Cevane-3beta,4beta,6alpha,7alpha,14,15alpha,16beta,20-octol, 4,9-epoxy-, 6,7-diacetate 15-((-)-2-methylbutyrate) 3-(2-methylcrotonate), (Z)-Q27275139CEVANE-3,4,6,7,14,15,16,20-OCTOL, 4,9-EPOXY-, 6,7-DIACETATE 15-((2R)-2-METHYLBUTANOATE) 3-((2Z)-2-METHYL-2-BUTENOATE), (3.BETA.,4.ALPHA.,6.ALPHA.,7.ALPHA.,15.ALPHA.,16.BETA.)-CEVANE-3,4,6,7,14,15,16,20-OCTOL, 4,9-EPOXY-, 6,7-DIACETATE 15-(2-METHYLBUTANOATE) 3-(2-METHYL-2-BUTENOATE), (3.BETA.(Z),4.ALPHA.,6.ALPHA.,7.ALPHA.,15.ALPHA.(R),16.BETA.)-CEVANE-3.BETA.,4.BETA.,6.ALPHA.,7.ALPHA.,14,15.ALPHA.,16.BETA.,20-OCTOL, 4,9-EPOXY-, 6,7-DIACETATE 15-((-)-2-METHYLBUTYRATE) 3-(2-METHYLCROTONATE), (Z)-